Protocol Library
Evidence-based dosing protocols with community validation. Find the right protocol for your goals.
Showing 16 protocols
A popular combination for tissue repair and recovery. BPC-157 and TB-500 work synergistically to promote healing.
FDA-approved protocol for chronic weight management. Requires slow titration to minimize side effects.
FDA-approved dual GIP/GLP-1 agonist protocol for superior weight loss results compared to single agonists.
FDA-approved weekly injection titration for weight management. Start at 0.25mg, increase every 4 weeks to 2.4mg maintenance dose.
FDA-approved daily oral tablet titration for weight management. Start at 1.5mg, increase every 30 days to 25mg maintenance dose.
FDA-approved weekly injection titration for weight management. Start at 2.5mg, increase by 2.5mg every 4 weeks. Maintenance: 5mg, 10mg, or 15mg.
Common research protocol for BPC-157. Typical dosing is 250-500mcg twice daily (morning and evening) for 4-6 weeks.
A synergistic combination for growth hormone optimization. CJC-1295 extends GH release while Ipamorelin provides the pulse.
FDA-approved weekly injection titration for type 2 diabetes. Same titration as Zepbound.
FDA-approved weekly injection titration for type 2 diabetes. Start at 0.25mg for 4 weeks, then 0.5mg maintenance. May increase to 1mg or 2mg.
Common research protocol for CJC-1295 (no DAC). Often combined with Ipamorelin.
Common research protocol for GHK-Cu (Copper Peptide). Used for skin rejuvenation and tissue healing. Typical dosing is 1-2mg daily.
Common research protocol for Ipamorelin. Typically dosed 2-3x daily on empty stomach.
FDA-approved GHRH analog for promoting natural growth hormone release. Safer alternative to direct GH administration.
Common research protocol for TB-500 (Thymosin Beta-4). Loading phase followed by maintenance.
Immune-modulating protocol using Thymosin Alpha-1 for enhanced immune function and recovery support.